Volume 23, Number 10—October 2017
Dispatch
Diagnosis of Fatal Human Case of St. Louis Encephalitis Virus Infection by Metagenomic Sequencing, California, 2016
Table 2
Test (hospital day sample collected) |
Laboratory |
Result |
---|---|---|
CSF studies | ||
SLEV, RT-PCR (9) | UCSF research lab | Positive |
SLEV, RT-PCR (3,9) | CDPH | Positive |
SLEV, RT-PCR (3,9) | CDC | Positive |
Viral culture (3,9) | CDC | Positive, confirmed as SLEV by RT-PCR |
SLEV, IgG/IgM antibody (3,9) | Quest Diagnostics | Negative, <1:10 |
SLEV, PRNT for neutralizing antibodies (9) | CDPH | Negative, <1:10 |
WNV, IgM | ||
WNV, PRNT for neutralizing antibodies (9) |
CDPH |
Negative, <1:10 |
Serum studies | ||
SLEV, RT-PCR (23) | CDPH | Negative |
SLEV, IgM antibody (23) | CDPH | Negative, <1:10 |
WNV, IgM antibody (23) | CDPH | Negative, <1:10 |
SLEV, PRNT for neutralizing antibodies (23) | CDPH | Negative, <1:10 |
WNV, PRNT for neutralizing antibodies (23) | CDPH | Borderline positive, 1:10 (normal <1:10) |
*Tests were performed after mNGS testing of patient CSF was positive from aliquots collected on hospital days 3 and 9. CDC, Centers for Disease Control and Prevention; CDPH, California Department of Public Health; CSF, cerebrospinal fluid; mNGS, metagenomic next-generation sequencing; PRNT, plaque-reduction neutralization testing; RT-PCR, reverse transcription PCR; SLEV, St. Louis encephalitis virus; UCSF, University of California, San Francisco; WNV, West Nile virus.
Page created: September 18, 2017
Page updated: September 18, 2017
Page reviewed: September 18, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.